Clinical Trials Directory

Trials / Completed

CompletedNCT03099863

Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Tract Infection

Cytoscopic Antibiotic Irrigant to Reduce Postoperative Urinary Infection: A Randomized Controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
242 (actual)
Sponsor
MetroHealth Medical Center · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Accepted

Summary

Postoperative urinary tract infections (UTIs) affect 20-30% of patients undergoing elective gynecologic surgery and have a significant socioeconomic impact and cost. Preoperative antibiotics, sterile operating techniques, postoperative antibiotic and non-antibiotic medical therapies have been utilized to attempt to decrease this rate with little improvement. Utilization of an intraoperative antibiotic cystoscopic irrigant may decrease postoperative UTIs. The investigators have designed a prospective randomized controlled study to evaluate the effectiveness of an antibiotic cystoscopic fluid in preventing postoperative urinary tract infections in women undergoing elective pelvic floor surgery with cystoscopy.

Conditions

Interventions

TypeNameDescription
DRUGCystoscopic Fluid containing Neosporin G. U. IrrigantNormal saline cystoscopic fluid containing Neosporin G. U. Irrigant 1mL/1000mL
PROCEDURECystoscopyDiagnostic cystoscopy performed during pelvic floor surgery
DRUGCystoscopic Fluid/PlaceboNormal saline cystoscopic fluid

Timeline

Start date
2016-04-01
Primary completion
2020-06-01
Completion
2020-06-01
First posted
2017-04-04
Last updated
2021-12-30
Results posted
2021-12-30

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03099863. Inclusion in this directory is not an endorsement.